Nanoparticle-mediated Treatment for Inflammatory Diseases
The present invention provides nanoparticles for treatment of inflammatory diseases. The nanoparticles preferably comprise chitosan and a siRNA targeting a mRNA encoding a pro-inflammatory cytokine, such as e.g. tnf-alfa. A preferred route of administration of the nanoparticles is by injection intraperitoneally.
Patents:CA 2,731,399
Inventor(s):
KJEMS JOERGEN [DK]; HOWARD KENNETH ALAN [DK]; BESENBACHER FLEMMING [DK]; DELEURAN BENT [DK]
Type of Offer:
Sale
« More Nanotech Patents« More Medical Patents